中银创新医疗混合C(010500)利润分配表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
收入 |
-291,790,447.49 |
-415,029,189.14 |
-278,569,331.58 |
-544,342,143.75 |
利息合计 |
316,011.61 |
134,095.58 |
446,360.02 |
296,083.84 |
其中:存款利息收入 |
316,011.61 |
134,095.58 |
446,360.02 |
296,083.84 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益合计 |
-156,982,716.53 |
-202,555,623.31 |
-231,204,026.89 |
-169,184,648.90 |
其中:股票投资收益 |
-165,744,718.88 |
-207,698,049.92 |
-238,343,196.29 |
-175,003,764.72 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
2,376,057.61 |
1,094,051.05 |
2,840,987.84 |
1,278,229.95 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
6,385,944.74 |
4,048,375.56 |
4,298,181.56 |
4,540,885.87 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
-137,204,687.92 |
-213,576,700.76 |
-50,299,727.30 |
-376,665,913.64 |
其他收入 |
2,080,945.35 |
969,039.35 |
2,488,062.59 |
1,212,334.95 |
费用 |
38,058,748.84 |
18,056,529.73 |
42,697,849.36 |
21,966,513.01 |
管理人报酬 |
29,690,896.18 |
14,032,189.35 |
33,388,174.04 |
17,386,673.93 |
基金托管费 |
4,948,482.79 |
2,338,698.28 |
5,564,695.72 |
2,897,779.01 |
销售服务费 |
3,122,626.50 |
1,537,954.04 |
3,458,737.66 |
1,583,706.29 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
296,743.37 |
147,688.06 |
286,241.94 |
98,353.78 |
利润总额 |
-329,849,196.33 |
-433,085,718.87 |
-321,267,180.94 |
-566,308,656.76 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年